This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sato, H Articles by Dohi, K Search for Related Content PubMed PubMed Citation Articles by Sato, H Articles by Dohi, K Social Bookmarking                         What's this?

FcRIIa polymorphism in Japanese patients with systemic lupus erythematosus

First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan

M Iwano

Y Akai

T Nishino

T Fujimoto

H Shiiki

K Dohi

First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan

Systemic lupus erythematosus (SLE) is an immune complex-mediated disease and organ damage is caused by the deposition of immune complex. Receptors which recognize the Fc portion of immunoglobulin G (FcgR) play a key role in the phagocytosis of immune complexes. As the gene encoding for FcgR of class IIa (FcRIIa) has two allelic forms, H131 and R131, which differ in their affinity to IgG2, this polymorphism might have implications in handling immune complex. We studied the distribution of the FcRIIa polymorphism in 90 Japanese patients with SLE. We also examined the association between FcRIIa polymorphism and the disease activity of SLE and the histopathological findings of lupus nephritis. FcRIIa polymorphism was determined by PCR and dot blot analysis. The allelic frequency of H131 in patients with SLE was significantly lower (H131/R131 ‘ 0.44/0.56) than that of normal controls (H131/R131 ‘ 0.62/0.38; P < 0.05). No significant association was observed between FcRIIa polymorphism and the clinical parameters for the activity of SLE. There was no association between FcRIIa polymorphism and the histological findings in lupus nephritis. The difference in the distribution of FcRIIa alleles between patients with SLE and normal subjects indicates that this polymorphism is a candidate of susceptibility gene for SLE in Japanese.

Key Words: Fcg receptor IIa polymorphism • systemic lupus erythematosus • anti-double-strand DNA antibody • serum complement • SLE disease activity index (SLEDAI)

Lupus, Vol. 10, No. 2, 97-101 (2001)
DOI: 10.1191/096120301677569675


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J-Y Chen, C M Wang, K-C Tsao, Y-H Chow, J-M Wu, C-L Li, H-H Ho, Y-J J. Wu, and S-F Luo Fc{gamma} receptor IIa, IIIa, and IIIb polymorphisms of systemic lupus erythematosus in Taiwan Ann Rheum Dis, July 1, 2004; 63(7): 877 - 880. [Abstract] [Full Text] [PDF]

				P D Khoa, T Sugiyama, and T Yokochi Fc{eta}receptor II polymorphism in Vietnamese patients with systemic lupus erythematosus Lupus, September 1, 2003; 12(9): 704 - 706. [Abstract] [PDF]

				K Manger, R Repp, M Jansen, M Geisselbrecht, R Wassmuth, N A C Westerdaal, A Pfahlberg, B Manger, J R Kalden, and J G J van de Winkel Fc{gamma} receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms Ann Rheum Dis, September 1, 2002; 61(9): 786 - 792. [Abstract] [Full Text] [PDF]